- Home
- APRE vs ATON Comparison
APRE vs ATON Comparison
Compare APRE & ATON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | APRE | ATON |
|---|---|---|
| Founded | 2006 | 1973 |
| Country | United States | British Virgin Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3M | 6.8M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | APRE | ATON |
|---|---|---|
| Price | $0.84 | $0.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $5.50 | $2.00 |
| AVG Volume (30 Days) | 252.0K | ★ 521.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.97 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.55 | $0.35 |
| 52 Week High | $2.76 | $13.80 |
Technical Indicators
Market Signals| Indicator | APRE | ATON |
|---|---|---|
| Relative Strength Index (RSI) | 52.68 | 39.44 |
| Support Level | $0.55 | $0.36 |
| Resistance Level | $1.02 | $3.30 |
| Average True Range (ATR) | 0.09 | 0.04 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 59.42 | 40.63 |
Price Performance
Historical ComparisonAbout APRE Aprea Therapeutics Inc.
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About ATON AlphaTON Capital Corp.
AlphaTON Capital Corp is a specialized digital asset treasury company focused on building and managing a strategic reserve of TON tokens and developing the Telegram ecosystem. The company implements a comprehensive treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, it provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform.